REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 212 filers reported holding REATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,606,482 | +5.8% | 15,756 | -5.6% | 0.00% | 0.0% |
| Q1 2023 | $1,518,091 | +248.2% | 16,697 | +452.3% | 0.00% | +300.0% |
| Q1 2020 | $436,000 | -95.9% | 3,023 | -94.1% | 0.00% | -95.8% |
| Q4 2019 | $10,551,000 | +205.4% | 51,611 | +19.9% | 0.02% | +200.0% |
| Q3 2019 | $3,455,000 | -22.8% | 43,035 | -9.3% | 0.01% | -27.3% |
| Q2 2019 | $4,477,000 | -49.1% | 47,454 | -53.8% | 0.01% | -50.0% |
| Q1 2019 | $8,788,000 | +80.6% | 102,816 | +72.8% | 0.02% | +100.0% |
| Q3 2018 | $4,865,000 | – | 59,501 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |